The AlphaLISA™ SureFire® Ultra™ Human Phospho-BCL-2 (Ser70) assay is a sandwich immunoassay for quantitative detection of phospho-BCL-2 (Ser70) in cellular lysates using Alpha Technology.
The oncogenic protein BCL-2 (B-cell lymphoma 2) is known for its role in preventing apoptosis. It is a 24-26 kDa protein that is found in the nuclear envelope, endoplasmic reticulum, and mitochondrial membrane. BCL-2 is categorized as a proto-oncogene since it is thought to be a significant antiapoptotic protein. Numerous cancers, such as breast, prostate, skin, colon, and pancreatic cancers, as well as neurological and autoimmune illnesses, have been linked to BCL-2 overexpression. The anti-apoptotic proteins BCL-XL, MCL-1, and BCL-W are all related. The BCL-2 family of proteins contains proapoptotic proteins such as Bax, BAD, Bak, Blk, and Bid.
The AlphaLISA SureFire Human Phospho-BCL-2 (Ser70) Detection Kit is a sandwich immunoassay for the quantitative detection of phospho-BCL-2 (Ser70) in cellular lysates, using Alpha Technology.
For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Application |
Protein Analysis & Detection
Protein Detection
|
---|---|
Assay Target |
BCL-2
|
Assay Target Class |
Phospho-protein
|
Assay Technology |
Alpha
|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Method |
Alpha
|
Shipping Conditions |
Shipped in Blue Ice
|
Target Species |
Human
|
Therapeutic Area |
Oncology
|
Unit Size |
500 Assay Points
|
This guide outlines further possible optimization of cellular and immunoassay parameters to ensure the best possible results are...
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.